King Pharmaceuticals KG Business Segments
| TTM Q1 '26 | ||
|---|---|---|
| Net premiums earned by Business | ||
| Legacy Reinsurance | $15.83M+24.9% | |
| Net premiums written by Business | ||
| Legacy Reinsurance | $8.86M+42.7% | |
| Reinsurance recoverable, allowance for credit loss by Business | ||
| AmTrust Reinsurance legacy business | $3.68M— | |
| Diversified Legacy Reinsurance | $2.77M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does King Pharmaceuticals break its business down?
- King Pharmaceuticals (KG) reports net premiums earned by business across 4 parts — AmTrust Legacy Segment, AmTrust Reinsurance, Diversified Legacy Segment and Legacy Reinsurance. Each is extracted from the segment footnotes and tracked over time.
- Where does King Pharmaceuticals's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in King Pharmaceuticals's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
